

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway (GO:0050853) | 8.80111546 |
| 2 | complement activation (GO:0006956) | 8.35394194 |
| 3 | positive regulation of B cell differentiation (GO:0045579) | 7.78007902 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.52199999 |
| 5 | interleukin-6-mediated signaling pathway (GO:0070102) | 7.51916151 |
| 6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 7.05732088 |
| 7 | protein maturation by protein folding (GO:0022417) | 6.94156290 |
| 8 | regulation of B cell differentiation (GO:0045577) | 6.93027074 |
| 9 | GDP-mannose metabolic process (GO:0019673) | 6.58297295 |
| 10 | ER overload response (GO:0006983) | 6.38870621 |
| 11 | negative regulation of B cell proliferation (GO:0030889) | 6.38485068 |
| 12 | cellular response to ethanol (GO:0071361) | 6.38182559 |
| 13 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 6.30419560 |
| 14 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 6.30419560 |
| 15 | Fc-gamma receptor signaling pathway (GO:0038094) | 6.30419560 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.26036048 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.26036048 |
| 18 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 6.21259530 |
| 19 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.73724739 |
| 20 | cellular response to zinc ion (GO:0071294) | 5.69784025 |
| 21 | positive regulation of protein homooligomerization (GO:0032464) | 5.59583567 |
| 22 | negative regulation of cellular response to insulin stimulus (GO:1900077) | 5.34953809 |
| 23 | protein activation cascade (GO:0072376) | 5.31581812 |
| 24 | humoral immune response (GO:0006959) | 5.30099391 |
| 25 | NIK/NF-kappaB signaling (GO:0038061) | 5.25226915 |
| 26 | regulation of gamma-delta T cell activation (GO:0046643) | 5.22710022 |
| 27 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 5.11460987 |
| 28 | embryonic process involved in female pregnancy (GO:0060136) | 5.01400639 |
| 29 | signal peptide processing (GO:0006465) | 4.99059503 |
| 30 | regulation of B cell proliferation (GO:0030888) | 4.97400689 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.94204843 |
| 32 | negative regulation of glycogen biosynthetic process (GO:0045719) | 4.89257791 |
| 33 | histone-serine phosphorylation (GO:0035404) | 4.88459051 |
| 34 | serine transport (GO:0032329) | 4.88350475 |
| 35 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 4.80697858 |
| 36 | labyrinthine layer development (GO:0060711) | 4.79390118 |
| 37 | regulation of energy homeostasis (GO:2000505) | 4.67399250 |
| 38 | L-serine transport (GO:0015825) | 4.62931684 |
| 39 | histone H3-K4 trimethylation (GO:0080182) | 4.57989454 |
| 40 | regulation of superoxide anion generation (GO:0032928) | 4.57195318 |
| 41 | positive regulation of Rap GTPase activity (GO:0032854) | 4.52398911 |
| 42 | cellular response to glucose starvation (GO:0042149) | 4.51907890 |
| 43 | mature B cell differentiation (GO:0002335) | 4.51298800 |
| 44 | B cell proliferation (GO:0042100) | 4.27901861 |
| 45 | retina homeostasis (GO:0001895) | 4.24444972 |
| 46 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.19262519 |
| 47 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 4.13408864 |
| 48 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 4.13408864 |
| 49 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.01964990 |
| 50 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.00972907 |
| 51 | fatty acid homeostasis (GO:0055089) | 3.98462885 |
| 52 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.94452760 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.92864190 |
| 54 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.88525599 |
| 55 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.88196442 |
| 56 | neutrophil activation (GO:0042119) | 3.87257076 |
| 57 | regulation of fibroblast apoptotic process (GO:2000269) | 3.84445042 |
| 58 | regulation of Rap GTPase activity (GO:0032317) | 3.83464343 |
| 59 | natural killer cell activation involved in immune response (GO:0002323) | 3.82387601 |
| 60 | macrophage activation involved in immune response (GO:0002281) | 3.77153248 |
| 61 | negative regulation of glycogen metabolic process (GO:0070874) | 3.75106435 |
| 62 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.73952182 |
| 63 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.67695992 |
| 64 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.67695992 |
| 65 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.67525280 |
| 66 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.66555432 |
| 67 | positive thymic T cell selection (GO:0045059) | 3.64303596 |
| 68 | positive regulation of protein oligomerization (GO:0032461) | 3.63662709 |
| 69 | negative regulation of glucose import (GO:0046325) | 3.63278696 |
| 70 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.62296958 |
| 71 | regulation of cellular extravasation (GO:0002691) | 3.62093004 |
| 72 | regulation of T cell migration (GO:2000404) | 3.61538805 |
| 73 | regulation of B cell activation (GO:0050864) | 3.61156416 |
| 74 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.59580828 |
| 75 | positive regulation of phosphatase activity (GO:0010922) | 3.57916888 |
| 76 | negative regulation of histone methylation (GO:0031061) | 3.57725330 |
| 77 | cellular response to unfolded protein (GO:0034620) | 3.56193311 |
| 78 | neutrophil activation involved in immune response (GO:0002283) | 3.56109006 |
| 79 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 3.55165326 |
| 80 | antibacterial humoral response (GO:0019731) | 3.54890165 |
| 81 | response to hydroperoxide (GO:0033194) | 3.54675170 |
| 82 | regulation of MHC class I biosynthetic process (GO:0045343) | 3.51116154 |
| 83 | proline transport (GO:0015824) | 3.49735871 |
| 84 | antimicrobial humoral response (GO:0019730) | 3.48801491 |
| 85 | B cell homeostasis (GO:0001782) | 3.47314628 |
| 86 | positive regulation of nuclease activity (GO:0032075) | 3.46528391 |
| 87 | glycosylceramide metabolic process (GO:0006677) | 3.44502062 |
| 88 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.44429268 |
| 89 | T cell selection (GO:0045058) | 3.44358380 |
| 90 | granulocyte activation (GO:0036230) | 3.43808462 |
| 91 | B cell activation (GO:0042113) | 3.40029078 |
| 92 | cellular response to topologically incorrect protein (GO:0035967) | 3.39302057 |
| 93 | mature B cell differentiation involved in immune response (GO:0002313) | 3.37267807 |
| 94 | positive regulation of immunoglobulin production (GO:0002639) | 3.37262609 |
| 95 | positive regulation of B cell activation (GO:0050871) | 3.37194328 |
| 96 | cellular response to interleukin-6 (GO:0071354) | 3.36519581 |
| 97 | regulation of platelet aggregation (GO:0090330) | 3.34742656 |
| 98 | regulation of respiratory burst (GO:0060263) | 3.34314202 |
| 99 | immune response-activating signal transduction (GO:0002757) | 3.34139014 |
| 100 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.33337252 |
| 101 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.33337252 |
| 102 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.33337252 |
| 103 | positive regulation of histone deacetylation (GO:0031065) | 3.33334486 |
| 104 | negative regulation of lipid catabolic process (GO:0050995) | 3.32767613 |
| 105 | positive regulation of autophagy (GO:0010508) | 3.32691183 |
| 106 | glomerular basement membrane development (GO:0032836) | 3.31160489 |
| 107 | rRNA catabolic process (GO:0016075) | 3.30668244 |
| 108 | lymphocyte homeostasis (GO:0002260) | 3.29659064 |
| 109 | regulation of cholesterol metabolic process (GO:0090181) | 3.29406761 |
| 110 | regulation of Rac protein signal transduction (GO:0035020) | 3.27502820 |
| 111 | negative regulation of glucose transport (GO:0010829) | 3.26467543 |
| 112 | peptidyl-lysine trimethylation (GO:0018023) | 3.23185233 |
| 113 | response to interleukin-15 (GO:0070672) | 3.21729908 |
| 114 | lipopolysaccharide metabolic process (GO:0008653) | 3.21438687 |
| 115 | defense response to protozoan (GO:0042832) | 3.20607608 |
| 116 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 3.20357582 |
| 117 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 3.20357582 |
| 118 | regulation of nuclease activity (GO:0032069) | 3.19777727 |
| 119 | positive regulation of steroid biosynthetic process (GO:0010893) | 3.17782922 |
| 120 | negative thymic T cell selection (GO:0045060) | 3.17394648 |
| 121 | ear development (GO:0043583) | 3.17210907 |
| 122 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.17159664 |
| 123 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.16482536 |
| 124 | vesicle targeting (GO:0006903) | 3.16175353 |
| 125 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.15879703 |
| 126 | ER-nucleus signaling pathway (GO:0006984) | 3.15283471 |
| 127 | respiratory burst (GO:0045730) | 3.14639499 |
| 128 | nucleotide-sugar metabolic process (GO:0009225) | 3.13421086 |
| 129 | developmental pigmentation (GO:0048066) | 3.13064958 |
| 130 | regulation of cellular response to insulin stimulus (GO:1900076) | 3.12774383 |
| 131 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.12740778 |
| 132 | histone H2A monoubiquitination (GO:0035518) | 3.10963138 |
| 133 | immune response-regulating cell surface receptor signaling pathway (GO:0002768) | 3.10482583 |
| 134 | positive regulation of B cell proliferation (GO:0030890) | 3.10026256 |
| 135 | skin morphogenesis (GO:0043589) | 3.09841307 |
| 136 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 3.08420704 |
| 137 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.07869566 |
| 138 | negative regulation of cell killing (GO:0031342) | 3.07869566 |
| 139 | intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631) | 3.06716637 |
| 140 | mannose metabolic process (GO:0006013) | 3.06538195 |
| 141 | regulation of B cell apoptotic process (GO:0002902) | 3.06292140 |
| 142 | positive regulation of glycolytic process (GO:0045821) | 3.05645406 |
| 143 | necroptotic process (GO:0070266) | 3.03842399 |
| 144 | thymic T cell selection (GO:0045061) | 3.03072381 |
| 145 | negative regulation of B cell activation (GO:0050869) | 3.02656353 |
| 146 | response to caffeine (GO:0031000) | 3.02377886 |
| 147 | activation of immune response (GO:0002253) | 3.00416144 |
| 148 | T cell homeostasis (GO:0043029) | 2.99818511 |
| 149 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.98486231 |
| 150 | positive regulation of mitochondrial fission (GO:0090141) | 2.98056281 |
| 151 | hepatocyte apoptotic process (GO:0097284) | 2.95918056 |
| 152 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.95793086 |
| 153 | regulation of histone H3-K9 methylation (GO:0051570) | 2.94952162 |
| 154 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.94840881 |
| 155 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.94378453 |
| 156 | natural killer cell differentiation (GO:0001779) | 2.94202339 |
| 157 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.93887264 |
| 158 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.92886919 |
| 159 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.91507026 |
| 160 | peptidyl-asparagine modification (GO:0018196) | 2.91168377 |
| 161 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.90386136 |
| 162 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.89973498 |
| 163 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.89658179 |
| 164 | B cell differentiation (GO:0030183) | 2.88147577 |
| 165 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.87733769 |
| 166 | leukocyte homeostasis (GO:0001776) | 2.87555571 |
| 167 | negative T cell selection (GO:0043383) | 2.87433915 |
| 168 | defense response to Gram-negative bacterium (GO:0050829) | 2.87121595 |
| 169 | activation of JUN kinase activity (GO:0007257) | 2.86761904 |
| 170 | cellular response to interleukin-15 (GO:0071350) | 2.85291842 |
| 171 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.83103729 |
| 172 | positive regulation of mast cell degranulation (GO:0043306) | 2.83103729 |
| 173 | positive regulation of interleukin-2 production (GO:0032743) | 2.82476074 |
| 174 | T cell costimulation (GO:0031295) | 2.82209268 |
| 175 | lymphocyte proliferation (GO:0046651) | 2.82199173 |
| 176 | L-fucose catabolic process (GO:0042355) | 2.81667868 |
| 177 | fucose catabolic process (GO:0019317) | 2.81667868 |
| 178 | L-fucose metabolic process (GO:0042354) | 2.81667868 |
| 179 | complement activation, classical pathway (GO:0006958) | 10.9675005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.34665010 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.40918606 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 5.07070683 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.80438713 |
| 5 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 4.02697359 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.92830723 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.91091239 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.75405139 |
| 9 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 3.63670765 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.61053864 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.59375803 |
| 12 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.46425907 |
| 13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.26556071 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.16179804 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.11412299 |
| 16 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.99910968 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.93188085 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.79235008 |
| 19 | MAF_26560356_Chip-Seq_TH1_Human | 2.71059648 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 2.65913340 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.54151224 |
| 22 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.39177380 |
| 23 | UTX_26944678_Chip-Seq_JUKART_Human | 2.39067943 |
| 24 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.35752253 |
| 25 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.35180158 |
| 26 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.32956108 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30083911 |
| 28 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.29813112 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.26251232 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.24934385 |
| 31 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.20189094 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 2.16260595 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.11275036 |
| 34 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.09994486 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.09000398 |
| 36 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.07307021 |
| 37 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.99222311 |
| 38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.93395858 |
| 39 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.90505601 |
| 40 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.82979889 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.81411091 |
| 42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.78643426 |
| 43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77649063 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.76760064 |
| 45 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.73525817 |
| 46 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.72223327 |
| 47 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.70691003 |
| 48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.70138943 |
| 49 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.70082600 |
| 50 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.68811401 |
| 51 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67454823 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.66495420 |
| 53 | MAF_26560356_Chip-Seq_TH2_Human | 1.63223636 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.59986134 |
| 55 | SPI1_23127762_ChIP-Seq_K562_Human | 1.54699005 |
| 56 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.53771092 |
| 57 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.53018345 |
| 58 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.52353648 |
| 59 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.50277857 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46828476 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43918628 |
| 62 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.38806078 |
| 63 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38290115 |
| 64 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36613735 |
| 65 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34347736 |
| 66 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32744861 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32188759 |
| 68 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.30196542 |
| 69 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29851617 |
| 70 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.26966529 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24711586 |
| 72 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.23403711 |
| 73 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.22110160 |
| 74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18923533 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.17088550 |
| 76 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.16513985 |
| 77 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11828279 |
| 78 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09316599 |
| 79 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.08940264 |
| 80 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06905153 |
| 81 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05975988 |
| 82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04673300 |
| 83 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.04060580 |
| 84 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04025593 |
| 85 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03594036 |
| 86 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03491484 |
| 87 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.02815614 |
| 88 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.02041072 |
| 89 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01997797 |
| 90 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 1.00514491 |
| 91 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.98792229 |
| 92 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98695011 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97898450 |
| 94 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96272537 |
| 95 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.95677186 |
| 96 | GATA3_26560356_Chip-Seq_TH1_Human | 0.94662186 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93883368 |
| 98 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.93745089 |
| 99 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93672637 |
| 100 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.93606276 |
| 101 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93433735 |
| 102 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.92650374 |
| 103 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92371236 |
| 104 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.92294601 |
| 105 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.92268297 |
| 106 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.91951959 |
| 107 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.91905205 |
| 108 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.90098259 |
| 109 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.89730678 |
| 110 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.88836305 |
| 111 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88502203 |
| 112 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.87606271 |
| 113 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87449406 |
| 114 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.86873700 |
| 115 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.85661418 |
| 116 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.85536068 |
| 117 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84721318 |
| 118 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83904272 |
| 119 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.83552179 |
| 120 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.83391897 |
| 121 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.83229923 |
| 122 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81636407 |
| 123 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.81311204 |
| 124 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.80891916 |
| 125 | P300_27268052_Chip-Seq_Bcells_Human | 0.80847234 |
| 126 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.80177605 |
| 127 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.79766103 |
| 128 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.79397252 |
| 129 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.79364935 |
| 130 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.79304367 |
| 131 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.78620788 |
| 132 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.78001651 |
| 133 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77620258 |
| 134 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77620258 |
| 135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77211009 |
| 136 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76722327 |
| 137 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.76413550 |
| 138 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.74712574 |
| 139 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74078102 |
| 140 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.73087178 |
| 141 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.72962387 |
| 142 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.72830134 |
| 143 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.72804852 |
| 144 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.72695787 |
| 145 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.72543851 |
| 146 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.72457752 |
| 147 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72315181 |
| 148 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.71778376 |
| 149 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.71735332 |
| 150 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71653057 |
| 151 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.71343230 |
| 152 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.71195207 |
| 153 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70807684 |
| 154 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.69037338 |
| 155 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.67940603 |
| 156 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.67746673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 5.74995321 |
| 2 | MP0000015_abnormal_ear_pigmentation | 5.54146139 |
| 3 | MP0001800_abnormal_humoral_immune | 5.10782013 |
| 4 | MP0005387_immune_system_phenotype | 4.90019467 |
| 5 | MP0001790_abnormal_immune_system | 4.90019467 |
| 6 | MP0003303_peritoneal_inflammation | 4.70827209 |
| 7 | MP0002452_abnormal_antigen_presenting | 3.77736657 |
| 8 | MP0002653_abnormal_ependyma_morphology | 3.40604308 |
| 9 | MP0003950_abnormal_plasma_membrane | 3.30187716 |
| 10 | MP0000685_abnormal_immune_system | 3.18811735 |
| 11 | MP0004036_abnormal_muscle_relaxation | 3.14609172 |
| 12 | MP0005000_abnormal_immune_tolerance | 3.07294712 |
| 13 | MP0002723_abnormal_immune_serum | 3.05810214 |
| 14 | MP0002420_abnormal_adaptive_immunity | 3.00122566 |
| 15 | MP0005671_abnormal_response_to | 2.95832002 |
| 16 | MP0001819_abnormal_immune_cell | 2.92326681 |
| 17 | MP0002398_abnormal_bone_marrow | 2.88749725 |
| 18 | MP0001529_abnormal_vocalization | 2.80253470 |
| 19 | MP0000716_abnormal_immune_system | 2.73596853 |
| 20 | MP0000689_abnormal_spleen_morphology | 2.63331928 |
| 21 | MP0004084_abnormal_cardiac_muscle | 2.57152359 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.50182391 |
| 23 | MP0001879_abnormal_lymphatic_vessel | 2.42575863 |
| 24 | MP0008260_abnormal_autophagy | 2.28162104 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.27415447 |
| 26 | MP0002429_abnormal_blood_cell | 2.22577386 |
| 27 | MP0005025_abnormal_response_to | 2.12813235 |
| 28 | MP0002277_abnormal_respiratory_mucosa | 2.12181211 |
| 29 | MP0006054_spinal_hemorrhage | 2.11504871 |
| 30 | MP0002722_abnormal_immune_system | 2.11075258 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 2.07654758 |
| 32 | MP0003436_decreased_susceptibility_to | 2.04857862 |
| 33 | MP0004145_abnormal_muscle_electrophysio | 2.02746242 |
| 34 | MP0010234_abnormal_vibrissa_follicle | 1.91204499 |
| 35 | MP0002095_abnormal_skin_pigmentation | 1.89668504 |
| 36 | MP0002419_abnormal_innate_immunity | 1.89188770 |
| 37 | MP0004270_analgesia | 1.88342837 |
| 38 | MP0005332_abnormal_amino_acid | 1.88191125 |
| 39 | MP0002396_abnormal_hematopoietic_system | 1.83108948 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.82950978 |
| 41 | MP0003763_abnormal_thymus_physiology | 1.81804473 |
| 42 | MP0002006_tumorigenesis | 1.79938725 |
| 43 | MP0010155_abnormal_intestine_physiology | 1.76860485 |
| 44 | MP0004130_abnormal_muscle_cell | 1.75187777 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.74242658 |
| 46 | MP0010386_abnormal_urinary_bladder | 1.64936513 |
| 47 | MP0009785_altered_susceptibility_to | 1.55775101 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.54471845 |
| 49 | MP0003183_abnormal_peptide_metabolism | 1.54468603 |
| 50 | MP0001873_stomach_inflammation | 1.49983338 |
| 51 | MP0004947_skin_inflammation | 1.47822034 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.47542829 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.47443909 |
| 54 | MP0004510_myositis | 1.44771004 |
| 55 | MP0002132_abnormal_respiratory_system | 1.44000428 |
| 56 | MP0002405_respiratory_system_inflammati | 1.35952772 |
| 57 | MP0004264_abnormal_extraembryonic_tissu | 1.34323646 |
| 58 | MP0002933_joint_inflammation | 1.34134979 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.23844508 |
| 60 | MP0001545_abnormal_hematopoietic_system | 1.23844508 |
| 61 | MP0003787_abnormal_imprinting | 1.23608789 |
| 62 | MP0000569_abnormal_digit_pigmentation | 1.21231512 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.19568173 |
| 64 | MP0003718_maternal_effect | 1.18954826 |
| 65 | MP0001986_abnormal_taste_sensitivity | 1.15855813 |
| 66 | MP0003866_abnormal_defecation | 1.14018890 |
| 67 | MP0002019_abnormal_tumor_incidence | 1.13087317 |
| 68 | MP0003075_altered_response_to | 1.11643162 |
| 69 | MP0002136_abnormal_kidney_physiology | 1.08157623 |
| 70 | MP0003724_increased_susceptibility_to | 1.05861764 |
| 71 | MP0001348_abnormal_lacrimal_gland | 1.05671770 |
| 72 | MP0005310_abnormal_salivary_gland | 1.03875699 |
| 73 | MP0001853_heart_inflammation | 1.03805241 |
| 74 | MP0005464_abnormal_platelet_physiology | 1.03356027 |
| 75 | MP0001727_abnormal_embryo_implantation | 1.00400638 |
| 76 | MP0003045_fibrosis | 0.99937173 |
| 77 | MP0009764_decreased_sensitivity_to | 0.99863788 |
| 78 | MP0008007_abnormal_cellular_replicative | 0.99277173 |
| 79 | MP0003091_abnormal_cell_migration | 0.99174862 |
| 80 | MP0008438_abnormal_cutaneous_collagen | 0.97932053 |
| 81 | MP0005076_abnormal_cell_differentiation | 0.92823021 |
| 82 | MP0005645_abnormal_hypothalamus_physiol | 0.90060286 |
| 83 | MP0001764_abnormal_homeostasis | 0.87613779 |
| 84 | MP0004142_abnormal_muscle_tone | 0.86784778 |
| 85 | MP0010352_gastrointestinal_tract_polyps | 0.85543867 |
| 86 | MP0004885_abnormal_endolymph | 0.85389129 |
| 87 | MP0005395_other_phenotype | 0.84358621 |
| 88 | MP0008874_decreased_physiological_sensi | 0.83623141 |
| 89 | MP0005075_abnormal_melanosome_morpholog | 0.83513360 |
| 90 | MP0008469_abnormal_protein_level | 0.80197274 |
| 91 | MP0004782_abnormal_surfactant_physiolog | 0.79945187 |
| 92 | MP0003795_abnormal_bone_structure | 0.79531960 |
| 93 | MP0000733_abnormal_muscle_development | 0.79498912 |
| 94 | MP0004924_abnormal_behavior | 0.77743987 |
| 95 | MP0005386_behavior/neurological_phenoty | 0.77743987 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.77675411 |
| 97 | MP0003566_abnormal_cell_adhesion | 0.77105287 |
| 98 | MP0003868_abnormal_feces_composition | 0.74117522 |
| 99 | MP0005023_abnormal_wound_healing | 0.72850411 |
| 100 | MP0008569_lethality_at_weaning | 0.72440110 |
| 101 | MP0002909_abnormal_adrenal_gland | 0.72374170 |
| 102 | MP0001188_hyperpigmentation | 0.71700505 |
| 103 | MP0002876_abnormal_thyroid_physiology | 0.71220692 |
| 104 | MP0008057_abnormal_DNA_replication | 0.71101878 |
| 105 | MP0002168_other_aberrant_phenotype | 0.69404506 |
| 106 | MP0002693_abnormal_pancreas_physiology | 0.69210860 |
| 107 | MP0000249_abnormal_blood_vessel | 0.67873266 |
| 108 | MP0005167_abnormal_blood-brain_barrier | 0.67755047 |
| 109 | MP0002295_abnormal_pulmonary_circulatio | 0.67749223 |
| 110 | MP0008961_abnormal_basal_metabolism | 0.67103600 |
| 111 | MP0002998_abnormal_bone_remodeling | 0.66650420 |
| 112 | MP0001663_abnormal_digestive_system | 0.64901257 |
| 113 | MP0001533_abnormal_skeleton_physiology | 0.64308032 |
| 114 | MP0000371_diluted_coat_color | 0.63789933 |
| 115 | MP0005174_abnormal_tail_pigmentation | 0.63645584 |
| 116 | MP0000490_abnormal_crypts_of | 0.62852875 |
| 117 | MP0002254_reproductive_system_inflammat | 0.61171851 |
| 118 | MP0002928_abnormal_bile_duct | 0.60812337 |
| 119 | MP0005621_abnormal_cell_physiology | 0.60720573 |
| 120 | MP0006036_abnormal_mitochondrial_physio | 0.60513958 |
| 121 | MP0005379_endocrine/exocrine_gland_phen | 0.59074166 |
| 122 | MP0002102_abnormal_ear_morphology | 0.58314140 |
| 123 | MP0001944_abnormal_pancreas_morphology | 0.57734251 |
| 124 | MP0001881_abnormal_mammary_gland | 0.57438118 |
| 125 | MP0002083_premature_death | 0.57189264 |
| 126 | MP0005166_decreased_susceptibility_to | 0.56881487 |
| 127 | MP0000920_abnormal_myelination | 0.56719442 |
| 128 | MP0004134_abnormal_chest_morphology | 0.56635116 |
| 129 | MP0000609_abnormal_liver_physiology | 0.55578310 |
| 130 | MP0001919_abnormal_reproductive_system | 0.53309655 |
| 131 | MP0003191_abnormal_cellular_cholesterol | 0.53053898 |
| 132 | MP0006082_CNS_inflammation | 0.52133126 |
| 133 | MP0009278_abnormal_bone_marrow | 0.50953532 |
| 134 | MP0008872_abnormal_physiological_respon | 0.50253737 |
| 135 | MP0005388_respiratory_system_phenotype | 0.50241562 |
| 136 | MP0002133_abnormal_respiratory_system | 0.50241562 |
| 137 | MP0000350_abnormal_cell_proliferation | 0.50040414 |
| 138 | MP0009763_increased_sensitivity_to | 0.48690471 |
| 139 | MP0000477_abnormal_intestine_morphology | 0.48631760 |
| 140 | MP0001958_emphysema | 0.48006118 |
| 141 | MP0003172_abnormal_lysosome_physiology | 0.46953667 |
| 142 | MP0002009_preneoplasia | 0.46655745 |
| 143 | MP0000767_abnormal_smooth_muscle | 0.46137195 |
| 144 | MP0009931_abnormal_skin_appearance | 0.44945392 |
| 145 | MP0008873_increased_physiological_sensi | 0.44619454 |
| 146 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.43904680 |
| 147 | MP0001191_abnormal_skin_condition | 0.43768319 |
| 148 | MP0003690_abnormal_glial_cell | 0.43192748 |
| 149 | MP0009643_abnormal_urine_homeostasis | 0.42454262 |
| 150 | MP0000003_abnormal_adipose_tissue | 0.42230945 |
| 151 | MP0003077_abnormal_cell_cycle | 0.42112721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nonimmune hydrops fetalis (HP:0001790) | 8.97762791 |
| 2 | Colitis (HP:0002583) | 8.05027045 |
| 3 | Abnormality of B cell number (HP:0010975) | 7.40921840 |
| 4 | B lymphocytopenia (HP:0010976) | 7.40921840 |
| 5 | Recurrent sinusitis (HP:0011108) | 7.08271126 |
| 6 | Cellulitis (HP:0100658) | 7.02098478 |
| 7 | Papilloma (HP:0012740) | 6.59922729 |
| 8 | Verrucae (HP:0200043) | 6.59922729 |
| 9 | Recurrent bronchitis (HP:0002837) | 6.43543759 |
| 10 | Inflammation of the large intestine (HP:0002037) | 6.22916049 |
| 11 | Gastrointestinal stroma tumor (HP:0100723) | 6.11998809 |
| 12 | Gastrointestinal inflammation (HP:0004386) | 5.99226333 |
| 13 | Recurrent viral infections (HP:0004429) | 5.97686692 |
| 14 | Hypoplasia of the pons (HP:0012110) | 5.31386709 |
| 15 | Type I transferrin isoform profile (HP:0003642) | 5.28507162 |
| 16 | Meningitis (HP:0001287) | 4.90412700 |
| 17 | IgM deficiency (HP:0002850) | 4.88205105 |
| 18 | Abnormality of the pons (HP:0007361) | 4.87684034 |
| 19 | Spastic paraparesis (HP:0002313) | 4.81627408 |
| 20 | Testicular atrophy (HP:0000029) | 4.77877321 |
| 21 | Reduced antithrombin III activity (HP:0001976) | 4.59656696 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 4.40909946 |
| 23 | Glucose intolerance (HP:0000833) | 4.26704263 |
| 24 | Recurrent pneumonia (HP:0006532) | 4.22265471 |
| 25 | Osteomyelitis (HP:0002754) | 4.21609122 |
| 26 | Nuclear cataract (HP:0100018) | 4.13417006 |
| 27 | Recurrent otitis media (HP:0000403) | 4.10631642 |
| 28 | Chronic sinusitis (HP:0011109) | 4.09118621 |
| 29 | Global brain atrophy (HP:0002283) | 4.08744459 |
| 30 | Megaloblastic anemia (HP:0001889) | 4.08470949 |
| 31 | Small epiphyses (HP:0010585) | 4.02616004 |
| 32 | Chronic otitis media (HP:0000389) | 4.02379726 |
| 33 | Emphysema (HP:0002097) | 4.02041724 |
| 34 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.84798121 |
| 35 | Cutaneous melanoma (HP:0012056) | 3.77645405 |
| 36 | Acute hepatic failure (HP:0006554) | 3.72622566 |
| 37 | Recurrent lower respiratory tract infections (HP:0002783) | 3.68199926 |
| 38 | Lymphopenia (HP:0001888) | 3.65847880 |
| 39 | Bronchitis (HP:0012387) | 3.65553167 |
| 40 | Sepsis (HP:0100806) | 3.61928978 |
| 41 | Gastrointestinal infarctions (HP:0005244) | 3.58645786 |
| 42 | Vertebral compression fractures (HP:0002953) | 3.55164257 |
| 43 | Thyroiditis (HP:0100646) | 3.55022321 |
| 44 | Hypokinesia (HP:0002375) | 3.54280886 |
| 45 | Abnormal protein glycosylation (HP:0012346) | 3.46028944 |
| 46 | Abnormal glycosylation (HP:0012345) | 3.46028944 |
| 47 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.46028944 |
| 48 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.46028944 |
| 49 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.44914880 |
| 50 | Prolonged partial thromboplastin time (HP:0003645) | 3.42049899 |
| 51 | Mitral stenosis (HP:0001718) | 3.36556599 |
| 52 | Abnormality of the intrinsic pathway (HP:0010989) | 3.35407356 |
| 53 | Abnormality of homocysteine metabolism (HP:0010919) | 3.30261420 |
| 54 | Homocystinuria (HP:0002156) | 3.30261420 |
| 55 | Recurrent fungal infections (HP:0002841) | 3.26843213 |
| 56 | Restrictive lung disease (HP:0002091) | 3.20364375 |
| 57 | Albinism (HP:0001022) | 3.19917663 |
| 58 | Gingival bleeding (HP:0000225) | 3.15995297 |
| 59 | Vasculitis (HP:0002633) | 3.14658892 |
| 60 | Abnormal glucose tolerance (HP:0001952) | 3.07046573 |
| 61 | Hypoalbuminemia (HP:0003073) | 2.94731040 |
| 62 | Abnormal albumin level (HP:0012116) | 2.94731040 |
| 63 | Stroke (HP:0001297) | 2.89956057 |
| 64 | IgA deficiency (HP:0002720) | 2.88319669 |
| 65 | Recurrent cutaneous fungal infections (HP:0011370) | 2.87583538 |
| 66 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.87583538 |
| 67 | Peritonitis (HP:0002586) | 2.86678482 |
| 68 | Recurrent abscess formation (HP:0002722) | 2.84397296 |
| 69 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.81544030 |
| 70 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.81544030 |
| 71 | Abnormality of glycolipid metabolism (HP:0010969) | 2.81544030 |
| 72 | Recurrent bacterial skin infections (HP:0005406) | 2.81446894 |
| 73 | Skin rash (HP:0000988) | 2.76190489 |
| 74 | Paraparesis (HP:0002385) | 2.72942547 |
| 75 | Curly hair (HP:0002212) | 2.72442390 |
| 76 | Vertebral arch anomaly (HP:0008438) | 2.67840000 |
| 77 | Abnormality of macrophages (HP:0004311) | 2.67156905 |
| 78 | IgG deficiency (HP:0004315) | 2.64948819 |
| 79 | Abnormality of the fingertips (HP:0001211) | 2.64271912 |
| 80 | Flattened epiphyses (HP:0003071) | 2.63875643 |
| 81 | Recurrent skin infections (HP:0001581) | 2.59958320 |
| 82 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.58394699 |
| 83 | Abnormality of T cell physiology (HP:0011840) | 2.57988378 |
| 84 | Progressive sensorineural hearing impairment (HP:0000408) | 2.57689443 |
| 85 | Abnormality of T cells (HP:0002843) | 2.51571160 |
| 86 | T lymphocytopenia (HP:0005403) | 2.51242050 |
| 87 | Viral hepatitis (HP:0006562) | 2.48241313 |
| 88 | Proximal tubulopathy (HP:0000114) | 2.44486598 |
| 89 | Hydroureter (HP:0000072) | 2.44457489 |
| 90 | Poor eye contact (HP:0000817) | 2.41908241 |
| 91 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.39793425 |
| 92 | Abnormality of T cell number (HP:0011839) | 2.39622175 |
| 93 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.36656646 |
| 94 | Prostate neoplasm (HP:0100787) | 2.36095672 |
| 95 | Follicular hyperkeratosis (HP:0007502) | 2.35595405 |
| 96 | Mediastinal lymphadenopathy (HP:0100721) | 2.34755008 |
| 97 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.31157096 |
| 98 | Supranuclear gaze palsy (HP:0000605) | 2.30073972 |
| 99 | Hyperglycinuria (HP:0003108) | 2.29227543 |
| 100 | Nasal polyposis (HP:0100582) | 2.28812333 |
| 101 | Abnormality of the prostate (HP:0008775) | 2.25465478 |
| 102 | Skin ulcer (HP:0200042) | 2.24733205 |
| 103 | Interstitial pulmonary disease (HP:0006530) | 2.23513443 |
| 104 | Trismus (HP:0000211) | 2.23419213 |
| 105 | Increased IgE level (HP:0003212) | 2.23320825 |
| 106 | Keratoconus (HP:0000563) | 2.23049024 |
| 107 | Increased corneal curvature (HP:0100692) | 2.23049024 |
| 108 | Abnormality of the pericardium (HP:0001697) | 2.22039984 |
| 109 | Neutropenia (HP:0001875) | 2.21453280 |
| 110 | Spontaneous abortion (HP:0005268) | 2.20972654 |
| 111 | Ulnar bowing (HP:0003031) | 2.20701390 |
| 112 | Abnormality of vitamin B metabolism (HP:0004340) | 2.18201387 |
| 113 | Microvesicular hepatic steatosis (HP:0001414) | 2.17851726 |
| 114 | Akinesia (HP:0002304) | 2.11407010 |
| 115 | Stomatitis (HP:0010280) | 2.10326340 |
| 116 | Asymmetry of the thorax (HP:0001555) | 2.09216328 |
| 117 | Diminished movement (HP:0002374) | 2.08496757 |
| 118 | Cerebral hemorrhage (HP:0001342) | 2.08356177 |
| 119 | Severe visual impairment (HP:0001141) | 2.07203974 |
| 120 | Lymphoma (HP:0002665) | 2.06444216 |
| 121 | Leukopenia (HP:0001882) | 2.05615161 |
| 122 | Bronchiectasis (HP:0002110) | 2.05260922 |
| 123 | Poikiloderma (HP:0001029) | 2.04898506 |
| 124 | Vascular calcification (HP:0004934) | 2.04169097 |
| 125 | Nephritis (HP:0000123) | 2.03828547 |
| 126 | Chest pain (HP:0100749) | 2.03005988 |
| 127 | Apathy (HP:0000741) | 2.00443976 |
| 128 | Agammaglobulinemia (HP:0004432) | 10.4089262 |
| 129 | Irregular vertebral endplates (HP:0003301) | 1.94917721 |
| 130 | Abnormal social behavior (HP:0012433) | 1.93854872 |
| 131 | Impaired social interactions (HP:0000735) | 1.93854872 |
| 132 | Pustule (HP:0200039) | 1.92919620 |
| 133 | Diminished motivation (HP:0000745) | 1.91806475 |
| 134 | Hypoplasia of the thymus (HP:0000778) | 1.91509936 |
| 135 | Purpura (HP:0000979) | 1.90292129 |
| 136 | Esotropia (HP:0000565) | 1.88938613 |
| 137 | Abnormality of methionine metabolism (HP:0010901) | 1.88836701 |
| 138 | Epistaxis (HP:0000421) | 1.86611551 |
| 139 | Abnormality of the nasal mucosa (HP:0000433) | 1.85079182 |
| 140 | Absent epiphyses (HP:0010577) | 1.82675801 |
| 141 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.82675801 |
| 142 | Eczematoid dermatitis (HP:0000976) | 1.79974207 |
| 143 | Dehydration (HP:0001944) | 1.79333397 |
| 144 | Macroorchidism (HP:0000053) | 1.76213870 |
| 145 | Arthropathy (HP:0003040) | 1.76101707 |
| 146 | Encephalitis (HP:0002383) | 1.73848714 |
| 147 | Papilledema (HP:0001085) | 1.69929791 |
| 148 | Thrombocytosis (HP:0001894) | 1.67423364 |
| 149 | Spontaneous hematomas (HP:0007420) | 1.67129109 |
| 150 | Obstructive lung disease (HP:0006536) | 1.66917665 |
| 151 | Chronic obstructive pulmonary disease (HP:0006510) | 1.66917665 |
| 152 | Basal cell carcinoma (HP:0002671) | 1.66686815 |
| 153 | Cubitus valgus (HP:0002967) | 1.65621502 |
| 154 | Arthralgia (HP:0002829) | 1.64933124 |
| 155 | Pulmonary infiltrates (HP:0002113) | 1.64375412 |
| 156 | Facial diplegia (HP:0001349) | 1.63934965 |
| 157 | Combined immunodeficiency (HP:0005387) | 1.62233280 |
| 158 | Abnormality of the intervertebral disk (HP:0005108) | 1.61945887 |
| 159 | Hepatitis (HP:0012115) | 1.58207985 |
| 160 | Severe combined immunodeficiency (HP:0004430) | 1.55868785 |
| 161 | Barrel-shaped chest (HP:0001552) | 1.53636609 |
| 162 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.51973350 |
| 163 | Limited elbow extension (HP:0001377) | 1.50833801 |
| 164 | Abnormal foot bone ossification (HP:0010675) | 1.50098810 |
| 165 | Eosinophilia (HP:0001880) | 1.49821038 |
| 166 | Hematochezia (HP:0002573) | 1.49797950 |
| 167 | Autoimmune thrombocytopenia (HP:0001973) | 1.48259863 |
| 168 | Myocardial infarction (HP:0001658) | 1.45671543 |
| 169 | Chronic diarrhea (HP:0002028) | 1.44479692 |
| 170 | Periodontitis (HP:0000704) | 1.42434444 |
| 171 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.41226217 |
| 172 | Villous atrophy (HP:0011473) | 1.41226217 |
| 173 | Abnormality of the vertebral endplates (HP:0005106) | 1.40892445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMKK2 | 7.17876306 |
| 2 | BRSK2 | 6.93854616 |
| 3 | ERN1 | 5.74814719 |
| 4 | MAP4K1 | 5.60680984 |
| 5 | MAP3K10 | 4.99758990 |
| 6 | FLT3 | 4.81656832 |
| 7 | GRK6 | 3.83319179 |
| 8 | CAMKK1 | 3.71041199 |
| 9 | RIPK4 | 3.29583020 |
| 10 | BRSK1 | 3.14959457 |
| 11 | IRAK2 | 2.96435020 |
| 12 | TYK2 | 2.71749365 |
| 13 | SYK | 2.60882994 |
| 14 | BLK | 2.60642642 |
| 15 | SIK2 | 2.51839595 |
| 16 | AKT3 | 2.49031891 |
| 17 | IRAK1 | 2.44621008 |
| 18 | CSF1R | 2.41950650 |
| 19 | TAOK3 | 2.22217079 |
| 20 | BTK | 2.16713924 |
| 21 | MAP3K13 | 2.12981816 |
| 22 | MET | 2.10382579 |
| 23 | MAP3K14 | 2.09970689 |
| 24 | JAK1 | 1.96515511 |
| 25 | LRRK2 | 1.68830283 |
| 26 | STK10 | 1.61787458 |
| 27 | KIT | 1.59678738 |
| 28 | CDK12 | 1.56000913 |
| 29 | PASK | 1.55856382 |
| 30 | LYN | 1.46107563 |
| 31 | EIF2AK3 | 1.26153731 |
| 32 | HCK | 1.22592009 |
| 33 | EEF2K | 1.13101045 |
| 34 | HIPK2 | 1.12479774 |
| 35 | IRAK3 | 1.09991084 |
| 36 | JAK3 | 1.05608758 |
| 37 | ITK | 1.03982476 |
| 38 | FGFR3 | 1.02196579 |
| 39 | TBK1 | 1.01148554 |
| 40 | CSK | 1.00348380 |
| 41 | STK38L | 0.96954112 |
| 42 | PIM1 | 0.94664528 |
| 43 | IKBKE | 0.93028215 |
| 44 | IRAK4 | 0.92949609 |
| 45 | BRD4 | 0.92406105 |
| 46 | MAPK7 | 0.92056667 |
| 47 | FGFR4 | 0.91942023 |
| 48 | LCK | 0.91841094 |
| 49 | PRKCH | 0.91125406 |
| 50 | SIK1 | 0.90430992 |
| 51 | WNK1 | 0.89579485 |
| 52 | FES | 0.87700000 |
| 53 | MAPKAPK5 | 0.87168623 |
| 54 | PRKCQ | 0.87063130 |
| 55 | TGFBR2 | 0.86951899 |
| 56 | MARK3 | 0.84748972 |
| 57 | IKBKB | 0.84430570 |
| 58 | TXK | 0.84380351 |
| 59 | PRKD2 | 0.77289745 |
| 60 | TEC | 0.76840015 |
| 61 | PRKD1 | 0.74776396 |
| 62 | MAP3K7 | 0.72333230 |
| 63 | NEK2 | 0.69618057 |
| 64 | CLK1 | 0.69463041 |
| 65 | PDK1 | 0.69348159 |
| 66 | PAK3 | 0.68708197 |
| 67 | IGF1R | 0.68594626 |
| 68 | CDK4 | 0.68148716 |
| 69 | TRIB3 | 0.67112203 |
| 70 | SIK3 | 0.64190718 |
| 71 | TNK2 | 0.63917720 |
| 72 | ACVR1B | 0.62526207 |
| 73 | DYRK1B | 0.62404283 |
| 74 | ALK | 0.61865847 |
| 75 | CDC42BPA | 0.60706597 |
| 76 | FYN | 0.59875224 |
| 77 | MAPK4 | 0.59045371 |
| 78 | PKN2 | 0.58159962 |
| 79 | MATK | 0.57909926 |
| 80 | PIK3CG | 0.57211899 |
| 81 | MAPKAPK3 | 0.56782310 |
| 82 | CAMK1G | 0.56731197 |
| 83 | CDK9 | 0.56471296 |
| 84 | MAPK12 | 0.56104838 |
| 85 | NME2 | 0.55960827 |
| 86 | MAP3K9 | 0.54443641 |
| 87 | MST4 | 0.53596118 |
| 88 | STK11 | 0.52142586 |
| 89 | BMPR1B | 0.50886296 |
| 90 | ABL1 | 0.50247165 |
| 91 | PRKAA2 | 0.50116839 |
| 92 | STK4 | 0.48865082 |
| 93 | CAMK2B | 0.48768285 |
| 94 | PKN1 | 0.48388678 |
| 95 | FRK | 0.48354566 |
| 96 | GRK1 | 0.48093822 |
| 97 | SGK3 | 0.47878399 |
| 98 | INSR | 0.47159656 |
| 99 | MAP3K11 | 0.45967138 |
| 100 | RET | 0.45741690 |
| 101 | BRAF | 0.45671778 |
| 102 | TTN | 0.45027015 |
| 103 | NEK9 | 0.44896237 |
| 104 | BCKDK | 0.44255772 |
| 105 | BUB1 | 0.43458933 |
| 106 | MAP3K12 | 0.43457278 |
| 107 | EPHB1 | 0.42225043 |
| 108 | EGFR | 0.41263458 |
| 109 | TLK1 | 0.39553673 |
| 110 | JAK2 | 0.39094657 |
| 111 | CDK6 | 0.36784092 |
| 112 | ZAP70 | 0.36679112 |
| 113 | MAP2K1 | 0.34633446 |
| 114 | CAMK1D | 0.33381982 |
| 115 | FGR | 0.32751096 |
| 116 | CSNK1D | 0.32364077 |
| 117 | PTK6 | 0.30549355 |
| 118 | PDPK1 | 0.30511277 |
| 119 | ABL2 | 0.30484599 |
| 120 | TAOK2 | 0.30479684 |
| 121 | CHUK | 0.30281176 |
| 122 | GRK5 | 0.29141557 |
| 123 | PRKCD | 0.28712691 |
| 124 | MAPK11 | 0.28528406 |
| 125 | MELK | 0.28150942 |
| 126 | TRIM28 | 0.28087727 |
| 127 | FGFR2 | 0.28063746 |
| 128 | MARK2 | 0.27144047 |
| 129 | KSR2 | 0.27024802 |
| 130 | FGFR1 | 0.26646626 |
| 131 | MAP2K3 | 0.24473798 |
| 132 | STK24 | 0.23958883 |
| 133 | EIF2AK2 | 0.22584611 |
| 134 | PRKAA1 | 0.20345884 |
| 135 | LATS1 | 0.19827579 |
| 136 | LMTK2 | 0.14918212 |
| 137 | MKNK2 | 0.13638482 |
| 138 | MAPK3 | 0.11938173 |
| 139 | PHKG1 | 0.10936893 |
| 140 | PHKG2 | 0.10936893 |
| 141 | RPS6KB2 | 0.10844990 |
| 142 | CHEK1 | 0.10753086 |
| 143 | CAMK1 | 0.10404827 |
| 144 | WNK4 | 0.08067552 |
| 145 | CSNK1A1 | 0.07635691 |
| 146 | MAP3K5 | 0.07622729 |
| 147 | TGFBR1 | 0.07425825 |
| 148 | MST1R | 0.07212890 |
| 149 | BMPR2 | 0.06287731 |
| 150 | PDK2 | 0.05479249 |
| 151 | STK3 | 0.05373778 |
| 152 | MAP2K4 | 0.00829053 |
| 153 | MAPK1 | -0.0305163 |
| 154 | GRK7 | -0.0047654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.26436470 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 6.12241012 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 5.01155226 |
| 4 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.97117687 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.71516974 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 2.29697839 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23441977 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.21100075 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.15007025 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.12599694 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.92842509 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.90260422 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.80235455 |
| 14 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.80119955 |
| 15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.79223678 |
| 16 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.79033436 |
| 17 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.78336725 |
| 18 | Olfactory transduction_Homo sapiens_hsa04740 | 1.72047840 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.68181426 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.66347673 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.64046353 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.61699569 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.54614474 |
| 24 | Basal transcription factors_Homo sapiens_hsa03022 | 1.53465625 |
| 25 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.49275073 |
| 26 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.47058840 |
| 27 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.38074975 |
| 28 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.30711598 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.29169520 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.27037111 |
| 31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26833782 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.20825376 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.18663564 |
| 34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.16255497 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.15645011 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.13487622 |
| 37 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.09252643 |
| 38 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.07581657 |
| 39 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.07436146 |
| 40 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06980932 |
| 41 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.05466998 |
| 42 | Hepatitis B_Homo sapiens_hsa05161 | 1.04613144 |
| 43 | Protein export_Homo sapiens_hsa03060 | 1.02280423 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02240864 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.99620669 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.99311188 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95005078 |
| 48 | RNA degradation_Homo sapiens_hsa03018 | 0.93807692 |
| 49 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.93705075 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 0.93043278 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.92281730 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87592114 |
| 53 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87487090 |
| 54 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.86083289 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84843092 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83763347 |
| 57 | Insulin resistance_Homo sapiens_hsa04931 | 0.83521554 |
| 58 | Apoptosis_Homo sapiens_hsa04210 | 0.82030120 |
| 59 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.81481752 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79506638 |
| 61 | Circadian rhythm_Homo sapiens_hsa04710 | 0.79028784 |
| 62 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.78676255 |
| 63 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77857578 |
| 64 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.77693710 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.77645575 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76276772 |
| 67 | Glioma_Homo sapiens_hsa05214 | 0.76197044 |
| 68 | Long-term potentiation_Homo sapiens_hsa04720 | 0.75375221 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74192460 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72934017 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.72618567 |
| 72 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.72273164 |
| 73 | Base excision repair_Homo sapiens_hsa03410 | 0.70771661 |
| 74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.69973025 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69336979 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.68756906 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65191296 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64278334 |
| 79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63432788 |
| 80 | Viral myocarditis_Homo sapiens_hsa05416 | 0.63251339 |
| 81 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62997190 |
| 82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61593850 |
| 83 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60321008 |
| 84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.59617019 |
| 85 | Prostate cancer_Homo sapiens_hsa05215 | 0.59115441 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.59081010 |
| 87 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58314223 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.58240231 |
| 89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.56922042 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.56099144 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.53632326 |
| 92 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.52726730 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52714804 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.52211828 |
| 95 | Shigellosis_Homo sapiens_hsa05131 | 0.51475853 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51180548 |
| 97 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.50843226 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.50629495 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.48613220 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46937733 |
| 101 | Legionellosis_Homo sapiens_hsa05134 | 0.46145973 |
| 102 | Phagosome_Homo sapiens_hsa04145 | 0.45777938 |
| 103 | Pertussis_Homo sapiens_hsa05133 | 0.43886803 |
| 104 | Asthma_Homo sapiens_hsa05310 | 0.40851211 |
| 105 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.40530735 |
| 106 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.40423607 |
| 107 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.40044817 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39592499 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39038293 |
| 110 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.38275889 |
| 111 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.38155425 |
| 112 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.37226923 |
| 113 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36732207 |
| 114 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.36642924 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.34599671 |
| 116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33719824 |
| 117 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.33183082 |
| 118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32111343 |
| 119 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.31286166 |
| 120 | Phototransduction_Homo sapiens_hsa04744 | 0.31110100 |
| 121 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30550178 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30411428 |
| 123 | ABC transporters_Homo sapiens_hsa02010 | 0.30333378 |
| 124 | Proteasome_Homo sapiens_hsa03050 | 0.29995899 |
| 125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.29854576 |
| 126 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.29583050 |
| 127 | Other glycan degradation_Homo sapiens_hsa00511 | 0.29172195 |
| 128 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.28676305 |
| 129 | Renin secretion_Homo sapiens_hsa04924 | 0.28003263 |
| 130 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.26650645 |
| 131 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.24878729 |
| 132 | Endocytosis_Homo sapiens_hsa04144 | 0.24548387 |
| 133 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.23671409 |
| 134 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.23643001 |
| 135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.22881230 |
| 136 | Colorectal cancer_Homo sapiens_hsa05210 | 0.22307942 |
| 137 | RNA polymerase_Homo sapiens_hsa03020 | 0.21961493 |
| 138 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.21827891 |
| 139 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.20764919 |
| 140 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.20370536 |
| 141 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.20156678 |
| 142 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.20088453 |

